Tsumura & Co operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tsumura & Co with three other
companies in this sector in Japan:
KYORIN Holdings, Incorporation
sales of 119.48 billion Japanese Yen [US$1.15 billion]
of which 99%
was Pharmaceutical Business),
Sawai Pharmaceutical Co., Ltd.
(123.49 billion Japanese Yen [US$1.19 billion]
of which 100%
was Pharmaceutical Business), and
Kaken Pharmaceutical Co Ltd
(109.73 billion Japanese Yen [US$1.06 billion]
of which 98%
Tsumura & Co reported sales of ¥112.63 billion (US$1.09 billion)
March of 2016.
a very small
increase of 2.0%
versus 2015, when the company's sales were ¥110.44 billion.
Sales at Tsumura & Co have increased during each of the previous five years
(and since 2011, sales have increased a total of 19%).